2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes: Developed by the task force on the management of cardiovascular …
N Marx, M Federici, K Schütt… - European heart …, 2023 - academic.oup.com
• The specific situation of the patient. Unless otherwise provided for by national regulations,
off-label use of medication should be limited to situations where it is in the patient's interest …
off-label use of medication should be limited to situations where it is in the patient's interest …
Metformin reduces all-cause mortality and diseases of ageing independent of its effect on diabetes control: a systematic review and meta-analysis
JM Campbell, SM Bellman, MD Stephenson… - Ageing Research …, 2017 - Elsevier
This systematic review investigated whether the insulin sensitiser metformin has a
geroprotective effect in humans. Pubmed and Embase were searched along with databases …
geroprotective effect in humans. Pubmed and Embase were searched along with databases …
[HTML][HTML] Metformin-associated lactic acidosis: Current perspectives on causes and risk
R DeFronzo, GA Fleming, K Chen, TA Bicsak - Metabolism, 2016 - Elsevier
Although metformin has become a drug of choice for the treatment of type 2 diabetes
mellitus, some patients may not receive it owing to the risk of lactic acidosis. Metformin …
mellitus, some patients may not receive it owing to the risk of lactic acidosis. Metformin …
Metformin in patients with type 2 diabetes and kidney disease: a systematic review
SE Inzucchi, KJ Lipska, H Mayo, CJ Bailey… - Jama, 2014 - jamanetwork.com
Importance Metformin is widely viewed as the best initial pharmacological option to lower
glucose concentrations in patients with type 2 diabetes mellitus. However, the drug is …
glucose concentrations in patients with type 2 diabetes mellitus. However, the drug is …
Clinical outcomes of metformin use in populations with chronic kidney disease, congestive heart failure, or chronic liver disease: a systematic review
MJ Crowley, CJ Diamantidis, JR McDuffie… - Annals of internal …, 2017 - acpjournals.org
Background: Recent changes to the US Food and Drug Administration boxed warning for
metformin will increase its use in persons with historical contraindications or precautions …
metformin will increase its use in persons with historical contraindications or precautions …
Association between preadmission metformin use and outcomes in intensive care unit patients with sepsis and type 2 diabetes: a cohort study
Q Yang, J Zheng, W Chen, X Chen, D Wen… - Frontiers in …, 2021 - frontiersin.org
Background: Sepsis is a deadly disease worldwide. Effective treatment strategy of sepsis
remains limited. There still was a controversial about association between preadmission …
remains limited. There still was a controversial about association between preadmission …
The current and potential therapeutic use of metformin—the good old drug
J Drzewoski, M Hanefeld - Pharmaceuticals, 2021 - mdpi.com
Metformin, one of the oldest oral antidiabetic agents and still recommended by almost all
current guidelines as the first-line treatment for type 2 diabetes mellitus (T2DM), has become …
current guidelines as the first-line treatment for type 2 diabetes mellitus (T2DM), has become …
[HTML][HTML] Mechanism and application of metformin in kidney diseases: An update
A Song, C Zhang, X Meng - Biomedicine & Pharmacotherapy, 2021 - Elsevier
Metformin is an oral antihyperglycemic drug widely used to treat type 2 diabetes mellitus
(T2DM), acting via indirect activation of 5′ Adenosine monophosphate-activated Protein …
(T2DM), acting via indirect activation of 5′ Adenosine monophosphate-activated Protein …
Association of metformin use with risk of lactic acidosis across the range of kidney function: a community-based cohort study
Importance Approximately 1 million patients in the United States with type 2 diabetes
mellitus and mild-to-moderate kidney disease do not receive guideline-directed therapy with …
mellitus and mild-to-moderate kidney disease do not receive guideline-directed therapy with …
Metformin for cardiovascular protection, inflammatory bowel disease, osteoporosis, periodontitis, polycystic ovarian syndrome, neurodegeneration, cancer …
M Ala, M Ala - ACS pharmacology & translational science, 2021 - ACS Publications
Diabetes is accompanied by several complications. Higher prevalence of cancers,
cardiovascular diseases, chronic kidney disease (CKD), obesity, osteoporosis, and …
cardiovascular diseases, chronic kidney disease (CKD), obesity, osteoporosis, and …